These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3628833)

  • 1. Effect of ascorbic acid on brain amphetamine concentrations in the rat.
    Kiely ME; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):287-90. PubMed ID: 3628833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of amphetamine and pilocarpine on the release of ascorbic and uric acid in several rat brain areas.
    Mueller K; Kunko PM
    Pharmacol Biochem Behav; 1990 Apr; 35(4):871-6. PubMed ID: 2345762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice.
    Brien JF; Kitney JC; Peachey JE; Rogers BJ
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):313-28. PubMed ID: 569889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some behavioural and EEG effects of ascorbic acid in rats.
    Wambebe C; Sokomba E
    Psychopharmacology (Berl); 1986; 89(2):167-70. PubMed ID: 3088632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of certain drugs on amphetamine-induced stereotyped behavior and brain amphetamine levels in the rat.
    Lal S; Missala K; Sourkes TL; Feldmuller F
    Biol Psychiatry; 1974 Aug; 9(1):3-10. PubMed ID: 4156181
    [No Abstract]   [Full Text] [Related]  

  • 6. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.
    Tolbert LC; Thomas TN; Middaugh LD; Zemp JW
    Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between apomorphine and amphetamine-induced rotational behaviour in rats with a unilateral nigrostriatal pathway lesion.
    Casas M; Ferré S; Cobos A; Cadafalch J; Grau JM; Jané F
    Neuropharmacology; 1988 Jun; 27(6):657-9. PubMed ID: 3138559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3H-amphetamine concentrations in the brains of young and aged rats: implications for assessment of drug effects in aged animals.
    Truex LL; Schmidt MJ
    Neurobiol Aging; 1980; 1(1):93-5. PubMed ID: 7196508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.
    Zwoliński J; Buczko W
    Pol J Pharmacol Pharm; 1977; 29(3):313-9. PubMed ID: 560684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regional distribution of d-amphetamine and local glucose utilization in rat brain during continuous amphetamine administration.
    Eison MS; Eison AS; Ellison G
    Exp Brain Res; 1981; 43(3-4):281-8. PubMed ID: 7196337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction of psychotropic drugs. I. Divergent effect of mianserin on pharmacokinetics and pharmacodynamics of amphetamine.
    Chodera A; Cenajek D; Godlewski J
    Pol J Pharmacol Pharm; 1979; 31(6):609-13. PubMed ID: 575858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative biochemical and behavioural effects of fencamfamine and dl-amphetamine in rats.
    Aizenstein ML; Scavone C; Bernardi MM; Delucia R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):187-94. PubMed ID: 6684314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism.
    White LK; Carpenter M; Block M; Basse-Tomusk A; Gardiner TW; Rebec GV
    Psychopharmacology (Berl); 1988; 94(2):284-7. PubMed ID: 2832869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracisternally administered adenosine and inosine on apomorphine- and amphetamine-induced stereotyped behaviour in rats.
    Singh J
    Indian J Physiol Pharmacol; 1990 Jan; 34(1):45-7. PubMed ID: 2361724
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
    Dickinson SL; Gadie B; Tulloch IF
    Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial environment influences amphetamine-induced stereotypy: subsequently environment change has little effect.
    Beck CH; Chow HL; Cooper SJ
    Behav Neural Biol; 1986 Nov; 46(3):383-97. PubMed ID: 3814044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5,7-Dihydroxytryptamine lesions of the amygdala reduce amphetamine- and apomorphine-induced stereotyped behaviour in the rat.
    Carter CJ; Pycock CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):235-8. PubMed ID: 7190651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on cyproheptadine-amphetamine interaction after pretreatment with 6-hydroxydopamine.
    Chodera A; Cenajek D; Bobrowska L
    Acta Physiol Pol; 1984; 35(5-6):426-31. PubMed ID: 6443726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of previous d-amphetamine treatment on the disposition and lethality of fenfluramine in the rat.
    Hunsinger RN; Kibbe AH; Wilson MC
    Toxicol Appl Pharmacol; 1985 Jun; 79(2):236-45. PubMed ID: 4002225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methylphenidate pretreatment on the behavioral and biochemical responses to amphetamine.
    Kolta MG; Shreve P; Uretsky NJ
    Eur J Pharmacol; 1985 Nov; 117(2):279-82. PubMed ID: 4076347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.